When using oncogenic gene sets, a correlation was revealed with KRAS and P53, common genes with mutation in pancreatic cancer; it has been reported that KRAS and P53 are associated with chemoresistance [23, 24]. Here, KRAS is linked to pancreatic neoplasm.